Tag: Psychedelic-assisted therapy

Emyria Expands National Psychedelic Clinic Network as Revenue Surges 210%

by Psychedelics.Media Team

July 29, 2026

Emyria (ASX: EMD) has released its June 2026 quarterly update, highlighting strong revenue growth, national clinic expansion and encouraging early ...

Page 2 of 2 Prev 1 2

No Result

View All Result

Home
News
Business
Policy & Regulation
Research
Health & Therapy
Opinion
Contact

Not enough quota to unlock this post

Unlock left : 0

Tag: Psychedelic-assisted therapy

Emyria Expands National Psychedelic Clinic Network as Revenue Surges 210%

Newsletter

Stay Ahead of Psychedelic Medicine

Recommended

Clinical-Stage Psychedelic Drug Developers That Matter Most in 2026

Inside the Psychedelic Mind: How Music, Imagery and Environment Could Shape the Future of Therapy

Popular Story

Incannex and the Next Test for Psychedelic Medicine

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

The Global Psychedelic Medicine Conference & Events Calendar 2026–2027

Eli Lilly Reportedly Nears Acquisition of AtaiBeckley in Potential Landmark Deal for Psychedelic Medicine

AbbVie’s $906M Psychedelic Bet: What It Means for Psychedelic Medicine

Recent Posts

Categories

Free Weekly Newsletter

Not enough quota to unlock this post

Are you sure want to cancel subscription?